Marianne E. Yee

761 total citations
40 papers, 425 citations indexed

About

Marianne E. Yee is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, Marianne E. Yee has authored 40 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 27 papers in Hematology and 12 papers in Physiology. Recurrent topics in Marianne E. Yee's work include Hemoglobinopathies and Related Disorders (31 papers), Blood groups and transfusion (21 papers) and Erythrocyte Function and Pathophysiology (12 papers). Marianne E. Yee is often cited by papers focused on Hemoglobinopathies and Related Disorders (31 papers), Blood groups and transfusion (21 papers) and Erythrocyte Function and Pathophysiology (12 papers). Marianne E. Yee collaborates with scholars based in United States, Canada and Jamaica. Marianne E. Yee's co-authors include Ross M. Fasano, Cassandra D. Josephson, Sean R. Stowell, Anne Winkler, John D. Roback, Naomi L.C. Luban, Erin Meyer, Peter A. Lane, John Horan and Jeanne E. Hendrickson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

Marianne E. Yee

36 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marianne E. Yee United States 13 316 302 138 57 31 40 425
Moji Awogbade United Kingdom 15 466 1.5× 607 2.0× 68 0.5× 205 3.6× 6 0.2× 29 687
Charles Knupp United States 12 241 0.8× 152 0.5× 28 0.2× 17 0.3× 30 1.0× 28 414
Pustika Amalia Wahidiyat Indonesia 10 245 0.8× 295 1.0× 33 0.2× 78 1.4× 3 0.1× 40 398
Fatma Soliman Elsayed Ebeid Egypt 11 140 0.4× 168 0.6× 25 0.2× 51 0.9× 3 0.1× 58 347
Carmelo Magnano Italy 8 274 0.9× 330 1.1× 19 0.1× 52 0.9× 3 0.1× 13 408
L.A. Kay United Kingdom 10 82 0.3× 86 0.3× 25 0.2× 32 0.6× 63 2.0× 16 244
Paolo Rigano Italy 17 367 1.2× 450 1.5× 52 0.4× 121 2.1× 1 0.0× 33 524
Miranda Athanassiou‐Metaxa Greece 15 402 1.3× 424 1.4× 39 0.3× 109 1.9× 1 0.0× 29 587
R.A. Rojer Netherlands 10 324 1.0× 432 1.4× 107 0.8× 48 0.8× 16 518
Beatrice Files United States 9 347 1.1× 396 1.3× 50 0.4× 137 2.4× 1 0.0× 15 464

Countries citing papers authored by Marianne E. Yee

Since Specialization
Citations

This map shows the geographic impact of Marianne E. Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne E. Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne E. Yee more than expected).

Fields of papers citing papers by Marianne E. Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne E. Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne E. Yee. The network helps show where Marianne E. Yee may publish in the future.

Co-authorship network of co-authors of Marianne E. Yee

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne E. Yee. A scholar is included among the top collaborators of Marianne E. Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne E. Yee. Marianne E. Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yee, Marianne E., Patricia E. Zerra, James McCoy, et al.. (2024). Post‐transfusion biotin‐labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance. Transfusion. 64(5). 800–807. 1 indexed citations
2.
Israelyan, Narek, Sunitha Vege, David F. Friedman, et al.. (2024). RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA. Transfusion. 64(3). 526–535. 6 indexed citations
3.
Yee, Marianne E., Mischa L. Covington, Patricia E. Zerra, et al.. (2024). Survival of transfused red blood cells from a donor with alpha‐thalassemia trait in a recipient with sickle cell disease. Transfusion. 64(6). 1109–1115. 2 indexed citations
4.
Adamkiewicz, Thomas V., Marianne E. Yee, Stepy Thomas, et al.. (2023). Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines. Blood Advances. 7(21). 6751–6761. 8 indexed citations
5.
O’Brien, Sarah H., Sherif M. Badawy, Seth J. Rotz, et al.. (2022). The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Blood Advances. 6(2). 679–685. 6 indexed citations
6.
Yee, Marianne E., et al.. (2022). Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange. Transfusion. 62(3). 584–593. 3 indexed citations
7.
Yee, Marianne E., Richard O. Francis, Naomi L.C. Luban, et al.. (2022). Glucose‐6‐phosphate dehydrogenase deficiency is more prevalent in Duffy‐null red blood cell transfusion in sickle cell disease. Transfusion. 62(3). 551–555. 4 indexed citations
8.
O’Brien, Sarah H., Sherif M. Badawy, Seth J. Rotz, et al.. (2021). The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatric Blood & Cancer. 68(8). e28967–e28967. 10 indexed citations
9.
Niss, Omar, Adam Lane, Monika Asnani, et al.. (2020). Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. Blood Advances. 4(7). 1501–1511. 33 indexed citations
10.
Hawkins, Lauren, Cynthia Sinha, Diana Ross, et al.. (2020). Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study. BMC Pediatrics. 20(1). 172–172. 12 indexed citations
11.
Chonat, Satheesh, Connie M. Arthur, Patricia E. Zerra, et al.. (2019). Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Transfusion Clinique et Biologique. 26(2). 130–134. 14 indexed citations
12.
Zahr, Rima S., Marianne E. Yee, Katherine Twombley, et al.. (2019). Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatric Nephrology. 34(8). 1435–1445. 16 indexed citations
13.
Arthur, Connie M., Satheesh Chonat, Ross M. Fasano, et al.. (2019). Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions. Transfusion Medicine Reviews. 33(4). 217–224. 25 indexed citations
14.
Landry, April M., et al.. (2018). Sensorineural hearing loss in children with sickle cell disease. International Journal of Pediatric Otorhinolaryngology. 118. 110–114. 9 indexed citations
15.
Goudy, Steven L., et al.. (2018). Adenotonsillectomy in children with sickle cell disease and obstructive sleep apnea. International Journal of Pediatric Otorhinolaryngology. 111. 158–161. 12 indexed citations
16.
17.
Yee, Marianne E., Peter A. Lane, David R. Archer, et al.. (2017). Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia. Blood Cells Molecules and Diseases. 69. 65–70. 20 indexed citations
18.
19.
Yee, Marianne E., et al.. (2015). Hemoglobin F Only Syndrome at Birth. Journal of Pediatric Hematology/Oncology. 38(1). e32–e34. 2 indexed citations
20.
Grove, John, A. Grandinetti, J. David Curb, et al.. (2009). Association of Fibrinogen with Parkinson Disease in Elderly Japanese-American Men: A Prospective Study. Neuroepidemiology. 34(1). 50–54. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026